A Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia - Related Studies

A Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia

This study has been completed.

Study NCT00035191. Last updated on March 14, 2007. Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Dementia, Vascular

2	Additional conditions recognized in this trial
		Dementia

3	More general conditions related to this trial
		Arterial Occlusive Diseases
		Arteriosclerosis
		Brain Diseases
		Cardiovascular Diseases
		Central Nervous System Diseases
		Cerebrovascular Disorders
		Delirium, Dementia, Amnestic, Cognitive Disorders
		Intracranial Arterial Diseases
		Intracranial Arteriosclerosis
		Mental Disorders
		Nervous System Diseases
		Vascular Diseases

4	Interventions listed in this trial
		galantamine

5	More general drug interventions related to this trial
		Autonomic Agents
		Central Nervous System Agents
		Cholinergic Agents
		Cholinesterase Inhibitors
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Nootropic Agents
		Parasympathomimetics
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		Johnson &Johnson Pharmaceutical Research &Development, L.L.C.